Use of Mobile Devices and the Internet to Streamline an Asthma Clinical Trial
| Status: | Completed |
|---|---|
| Conditions: | Asthma |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 12 - 17 |
| Updated: | 12/21/2018 |
| Start Date: | October 2013 |
| End Date: | February 17, 2017 |
Asthma is an inflammatory disease that imposes a significant burden affecting an estimated
300 million persons and 20% of all children worldwide. It is one of the most common chronic
diseases of childhood and is a leading cause of school absenteeism. There continues to be a
great need for clinical trials in asthma but traditional clinical trials are expensive and
reasons cited by patients for non-participation are extra inconvenience and logistical
barriers. Study designs which are patient centered and reduce trial costs are needed. The
long-range goal of this application is to transform the paradigm of clinical research into a
more efficient and cost-effective enterprise by capitalizing upon current widely used mobile
electronic means of communication and information transfer.
This innovative project is a streamlined clinical trial that will run concurrently with a
nearly identical traditional clinical trial, "Long-acting Beta Agonist Step Down Study"
(LASST) which will allow for direct comparison of processes and outcomes between the
streamlined and traditional approach. Children 12 to 17 years old with asthma will be
randomized to participate in this project (streamlined trial) or LASST (traditional trial).
In this proposal we will: measure comprehension of study information using an original
questionnaire, Research Participant Assessment (developed at Nemours), following a parental
permission/assent process delivered over the internet in a dynamic interactive multi-media
format (Specific Aim 1); measure the efficiency of participant driven data entry from home
into a Research Electronic Data Capture (REDCap) online database using the iPad, and quality
of spirometry with the EasyOne Plus handheld meter with remote coaching using the iPad
(Specific Aim 2); test whether the streamlined approach has a "trial effect" by comparing the
differences in Asthma Control Test (ACT) scores following 12 weeks of study drug treatment in
children randomized to this project compared to LASST. We will collect effort reporting data
to compare personnel costs between the trials. If this streamlined project lacks a "trial
effect" and reduces costs compared to LASST, the methodologies would be generalizable to
studies which include adults and other diseases.
300 million persons and 20% of all children worldwide. It is one of the most common chronic
diseases of childhood and is a leading cause of school absenteeism. There continues to be a
great need for clinical trials in asthma but traditional clinical trials are expensive and
reasons cited by patients for non-participation are extra inconvenience and logistical
barriers. Study designs which are patient centered and reduce trial costs are needed. The
long-range goal of this application is to transform the paradigm of clinical research into a
more efficient and cost-effective enterprise by capitalizing upon current widely used mobile
electronic means of communication and information transfer.
This innovative project is a streamlined clinical trial that will run concurrently with a
nearly identical traditional clinical trial, "Long-acting Beta Agonist Step Down Study"
(LASST) which will allow for direct comparison of processes and outcomes between the
streamlined and traditional approach. Children 12 to 17 years old with asthma will be
randomized to participate in this project (streamlined trial) or LASST (traditional trial).
In this proposal we will: measure comprehension of study information using an original
questionnaire, Research Participant Assessment (developed at Nemours), following a parental
permission/assent process delivered over the internet in a dynamic interactive multi-media
format (Specific Aim 1); measure the efficiency of participant driven data entry from home
into a Research Electronic Data Capture (REDCap) online database using the iPad, and quality
of spirometry with the EasyOne Plus handheld meter with remote coaching using the iPad
(Specific Aim 2); test whether the streamlined approach has a "trial effect" by comparing the
differences in Asthma Control Test (ACT) scores following 12 weeks of study drug treatment in
children randomized to this project compared to LASST. We will collect effort reporting data
to compare personnel costs between the trials. If this streamlined project lacks a "trial
effect" and reduces costs compared to LASST, the methodologies would be generalizable to
studies which include adults and other diseases.
Introduction Phase III / IV clinical trials are expensive and time consuming and often suffer
from poor enrollment and retention rates. Pediatric trials are particularly difficult because
scheduling around the parent, participant and potentially other sibling schedules can be
burdensome. We are evaluating using the internet and mobile devices to conduct the consent
process and study visits in a streamlined pediatric asthma trial. Our hypothesis is that
these study processes will be noninferior and will be less expensive compared to a
traditional pediatric asthma trial.
Materials/Methods Parents and participants, aged 12 through 17 years, complete the informed
consent process by viewing a multi-media website containing a consent video and study
material in the streamlined trial. Participants are provided an iPad with WiFi (wireless
internet) and EasyOne spirometer for use during FaceTime visits and online twice daily
symptom reporting during an 8-week run-in followed by 12-week study period. Outcomes are
compared with participants completing a similarly designed traditional trial comparing the
same treatments within the same pediatric health-system. After 8 weeks of open-label Advair
250/50 twice daily, participants in both trial types are randomized to Advair 250/50, Flovent
250, or Advair 100/50 given 1 inhalation twice daily. Study staff track time spent to
determine study costs.
Results Participants have been enrolled in the streamlined and traditional trials and
recruitment is ongoing.
Conclusions This project will provide important information on both clinical and economic
outcomes for a novel method of conducting clinical trials. The results will be broadly
applicable to trials of other diseases.
from poor enrollment and retention rates. Pediatric trials are particularly difficult because
scheduling around the parent, participant and potentially other sibling schedules can be
burdensome. We are evaluating using the internet and mobile devices to conduct the consent
process and study visits in a streamlined pediatric asthma trial. Our hypothesis is that
these study processes will be noninferior and will be less expensive compared to a
traditional pediatric asthma trial.
Materials/Methods Parents and participants, aged 12 through 17 years, complete the informed
consent process by viewing a multi-media website containing a consent video and study
material in the streamlined trial. Participants are provided an iPad with WiFi (wireless
internet) and EasyOne spirometer for use during FaceTime visits and online twice daily
symptom reporting during an 8-week run-in followed by 12-week study period. Outcomes are
compared with participants completing a similarly designed traditional trial comparing the
same treatments within the same pediatric health-system. After 8 weeks of open-label Advair
250/50 twice daily, participants in both trial types are randomized to Advair 250/50, Flovent
250, or Advair 100/50 given 1 inhalation twice daily. Study staff track time spent to
determine study costs.
Results Participants have been enrolled in the streamlined and traditional trials and
recruitment is ongoing.
Conclusions This project will provide important information on both clinical and economic
outcomes for a novel method of conducting clinical trials. The results will be broadly
applicable to trials of other diseases.
Main Trial
Inclusion Criteria:
- Age 12-17 years
- Physician diagnosed asthma (without any other co-morbid pulmonary disease) that is
well-controlled on medium dose inhaled corticosteroid and long-acting β2-agonist given
twice daily [Advair Diskus (fluticasone propionate/salmeterol) 250/50mcg; Advair HFA
(hydrofluoroalkane) (fluticasone propionate/salmeterol hydrofluoroalkane) 115/21mcg;
Symbicort (budesonide/formoterol) 160/4.5mcg; Dulera (mometasone/formoterol)
100/4.5mcg] based on an ACT score > 20, and the absence of unscheduled visits or use
of rescue prednisone for 4 weeks prior to enrollment
- Pre-bronchodilator forced expiratory volume in the first second > 70% predicted
- < 10 pack/year history of tobacco use and abstinence for at least 1 year
Exclusion Criteria:
- Chronic oral steroid therapy
- Hospitalization or urgent care visit within 4 weeks of the screening visit
- Near fatal asthma within 2 years of enrollment or high risk of near fatal or fatal
asthma 125-127
- Women who are pregnant or lactating
Parallel MICT and Parallel LASST
Inclusion Criteria:
- Age 12-17 years
- Physician diagnosed asthma (without any other co-morbid pulmonary disease) that is
well-controlled on medium dose inhaled corticosteroid and long-acting β2-agonist given
twice daily [Advair Diskus (fluticasone propionate/salmeterol) 250/50mcg; Advair HFA
(hydrofluoroalkane) (fluticasone propionate/salmeterol hydrofluoroalkane) 115/21mcg;
Symbicort (budesonide/formoterol) 160/4.5mcg; Dulera (mometasone/formoterol)
100/4.5mcg] based on an ACT score > 20, and the absence of unscheduled visits or use
of rescue prednisone for 4 weeks prior to enrollment
- < 10 pack/year history of tobacco use and abstinence for at least 1 year
Exclusion Criteria:
- Chronic oral steroid therapy
- Hospitalization or urgent care visit within 4 weeks of the screening visit
- Near fatal asthma within 2 years of enrollment or high risk of near fatal or fatal
asthma 125-127
- Women who are pregnant or lactating
We found this trial at
5
sites
Nemours Children's Hospital Nemours Children's Hospital in Orlando brings pediatric specialty care never before offered...
Click here to add this to my saved trials
Alfred I. duPont Hospital for Children Nemours began more than 70 years ago with the...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials